Sarepta Therapeutics Q4 Profit Increases, But Misses Estimates

Sarepta Therapeutics

95.51 CHF -10.71%

• Charts
• News
• Analysen

Kaufen Verkaufen

(RTTNews) - Sarepta Therapeutics (SRPT) announced a profit for its fourth quarter that increased from the same period last year but missed the Street estimates.

The company's bottom line totaled $159.0 million, or $1.50 per share. This compares with $45.7 million, or $0.47 per share, last year.

Excluding items, Sarepta Therapeutics reported adjusted earnings of $206.0 million or $1.90 per share for the period.

Analysts on average had expected the company to earn $2.06 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 65.9% to $658.4 million from $396.8 million last year.

Sarepta Therapeutics earnings at a glance (GAAP) :

-Earnings: $159.0 Mln. vs. $45.7 Mln. last year. -EPS: $1.50 vs. $0.47 last year. -Revenue: $658.4 Mln vs. $396.8 Mln last year.